These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1378156

  • 1. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
    Albergati F, Paternó E, Venuti RP, Boeri D, Lombardo I, Semino S, Viviani GL, Adezati L.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
    [Abstract] [Full Text] [Related]

  • 2. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
    Juttmann JR, de Vries Robles P, Venuti RP.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T, Yoshinaga K, Kamahara Y, Ikeda M, Goto Y, Arakawa K, Iimura I, Ishii M, Kokubu T, Takeda T.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.
    van der Does R, Eberhardt R, Derr I, Ehmer B.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S122-7. PubMed ID: 1378139
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antihypertensive profile of carvedilol.
    Meyer-Sabellek W, Agrawal B.
    Clin Investig; 1992; 70 Suppl 1():S43-52. PubMed ID: 1350484
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y, Nishikawa Y, Iizuka T, Zenimura N, Matsumoto T, Hiramatsu K, Komiya M.
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [Abstract] [Full Text] [Related]

  • 12. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Langdon CG, Baxter GA, Young PH.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S51-6. PubMed ID: 1721980
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    McTavish D, Campoli-Richards D, Sorkin EM.
    Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
    van der Does R, Widmann L, Uberbacher HJ, Hörrmann M, Machwirth M, Stienen U.
    Eur J Clin Pharmacol; 1990 Feb; 38 Suppl 2():S147-52. PubMed ID: 1974506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.